The Richmond Guide to Ketamine and Psychedelic Therapy

The Options in Richmond, Briefly

Greater Richmond has four practical paths to ketamine care and, more broadly, to psychedelic therapy, plus clinical trials. Here is what each one is, without ranking them.

At-home ketamine therapy. A licensed clinician evaluates you online and, if it is a good fit, prescribes a guided program you complete from home by telehealth. At-home providers charge $165 to $215 per session within a program.

In-clinic IV or IM ketamine. You receive provider-administered infusions or injections at a clinic. Alchemy Wellness in Henrico has offered this since 2019, and Infuse RVa serves the metro's southern edge in South Chesterfield and Petersburg; independent-clinic pricing is cash-pay.

Spravato (esketamine). This FDA-approved nasal spray for treatment-resistant depression is self-administered in a REMS-certified clinic under about two hours of monitoring. Foundation Medical Group provides it at Richmond and North Chesterfield locations.

Licensed psilocybin therapy. This is not available in Virginia. There is no state psilocybin program and no local decriminalization, so it is not a current option in the metro.

Clinical trials. Academic and research sites sometimes enroll studies of psychedelic-class treatments; participation is usually free if you qualify, but slots and eligibility are limited.

For a fuller picture of ketamine therapy in Virginia and where it is available, the sub-area list below covers the metro's counties and independent cities.

Which One Fits You

A quick way to narrow the choice, matched by situation rather than by which option is best.

• If you are managing treatment-resistant depression and want a route your insurance may cover, a REMS-certified Spravato clinic such as Foundation Medical Group is worth pricing first.
• If you prefer a traditional clinical setting and IV dosing with a provider in the room, an in-clinic IV or IM ketamine clinic like Alchemy Wellness fits.
• If you want to do the therapy from home on your own schedule, at-home ketamine therapy by telehealth fits, pending a clinician's approval.
• If you are drawn specifically to psilocybin or MDMA, neither is legally available for therapy in Virginia, so a clinical trial or ketamine are the routes open to you now.
• If out-of-pocket cost is your main concern, compare per-session prices across the at-home and independent in-clinic options before you commit to a course.

Ketamine and Psychedelic Therapy Across the Richmond Metro

In-person clinics cluster in the city of Richmond and its inner suburbs, but the metro spreads across several independent jurisdictions, so where you live changes how far you drive. In-clinic providers sit in Henrico (including the Glen Allen and Short Pump area), Chesterfield and Midlothian, and the Tri-Cities to the south, while at-home ketamine therapy is available the same way everywhere with a connection and a private space.

• City of Richmond and near-in neighborhoods
• Henrico County, including Glen Allen and Short Pump
• Chesterfield County, including Midlothian, Chester, and South Chesterfield
• North Chesterfield
• Hanover County, including Mechanicsville
• The Tri-Cities: Colonial Heights, Petersburg, and Hopewell

Because providers are scattered across these counties, a cross-town or cross-river drive is common for in-clinic care. At-home treatment removes that step, which matters more in a spread-out metro like this one.

Is Ketamine and Psychedelic Therapy Legal in Virginia?

Ketamine is legal. It is an FDA-approved Schedule III medication that a licensed clinician can prescribe, including off-label for depression, anxiety, and PTSD, and it can be delivered in a clinic or at home by telehealth for eligible adults. That is why ketamine is the psychedelic-class therapy you can actually start in Richmond right now.

Psilocybin and MDMA are not. Both remain Schedule I under Virginia and federal law, and no Richmond city or county has passed a decriminalization or deprioritization measure, despite state decriminalization bills that have repeatedly stalled in the General Assembly.⁹ Virginia enacted a 2026 law that would reschedule an FDA-approved psilocybin formulation only if and when the FDA approves one, and because no such approval exists, psilocybin remains illegal in Virginia today. The same is true for LSD and ayahuasca, which are not legally available for therapy, and MDMA-assisted therapy is not FDA-approved anywhere in the United States.

There is national momentum behind the category, however: in April 2026 a federal executive order directed the FDA and DEA to accelerate research into and access to psychedelic-based treatments for serious mental illness, and ketamine is the psychedelic-class treatment already available under medical supervision today.¹²

Why People Choose At-Home Care, and What the Evidence Shows

The main reason people in Richmond pick at-home ketamine therapy is access. Virginia sits below the national average for provider supply, so appointments can be hard to get, and at-home care skips the waitlists and the cross-county drive. The trade-off people weigh is the in-person clinical setting of an IV clinic against the convenience and lower per-session cost of treatment at home. It is also worth understanding how at-home dosing compares with IV before deciding.

On the evidence, more than 800,000 guided at-home sessions place Mindbloom among the largest at-home psychedelic-therapy providers. Its peer-reviewed subcutaneous outcomes (Parks 2026) cover depression, anxiety, and PTSD in a single peer-reviewed study, and its earlier sublingual research (Hull 2022 and Mathai 2024) add two more, alongside research preprints extending the evidence to grief, burnout, and sleep. It is the only at-home ketamine therapy provider with peer-reviewed PTSD outcomes.

_{¹ Subcutaneous, six-session course (Parks 2026). Response = at least a 50% reduction (PHQ-9/GAD-7) or a 10-point reduction (PCL-5); remission = final PHQ-9/GAD-7 under 5, or a 10-point reduction with PCL-5 under 33. ² Grief (PGD-13), n=503. ³ Burnout (MBI-GS), n=395. ⁴ Sleep (PHQ-9 Item 3), n=13,963; single-item measure, and ketamine is off-label for sleep. ᵃ Grief remission = no longer met diagnostic criteria (71.1% DSM-5-TR). ᵇ Burnout response = improved on at least one dimension (69.6%); remission = fell below the burnout threshold (59.5%). ᶜ Sleep remission = complete resolution (score 0). Individual results vary.}

Mindbloom offers tailored programs that use the psychedelic modality to work toward specific outcomes rather than only prescribing medication for them. Programs include Grief, Habit Change, Anxiety, Depression, Self-Love, and Burnout.

A few study-versus-study comparisons help place these numbers in context:

• Mindbloom's reported depression response is comparable to the rate reported in a study of first-line SSRIs, without a daily medication and faster (2 sessions versus four to six weeks).¹ ⁵
• Mindbloom's reported anxiety response is comparable to the rate reported in a study of first-line SSRIs, without a daily pill.¹ ⁵
• Mindbloom's reported at-home PTSD response rate exceeds the rate reported in the leading repeated-infusion IV ketamine trial (76.7% versus 67%).¹ ⁶
• Mindbloom's reported depression response (56.6%) is at or above the rate reported in the largest controlled trials of single-dose psilocybin for depression (about 37% to 42%), on a far larger published evidence base and delivered at home rather than in a full-day, in-person licensed-center session.¹ ⁷

How At-Home Ketamine Therapy Works, and What It Costs

The process starts with an online clinician evaluation. A licensed clinician reviews your history and goals and decides whether treatment is appropriate, so it is available to eligible adults after that review rather than on demand. If approved, you receive the medication and complete guided sessions from home, with preparation and follow-up built in and a clinician adjusting the plan to a personalized treatment frequency rather than a fixed schedule.

Ketamine sessions are done in a safe, supported setting: you set aside a quiet, private space, arrange a support person as directed, and have monitoring and check-ins around each session. Many people feel some relief relatively quickly, with benefits that can build over the course of treatment rather than all at once.

On cost, at-home programs run $165 to $215 per session, and you can use HSA or FSA funds with possible out-of-network reimbursement; see pricing for the current program options. Independent IV clinics in Richmond are typically cash-pay at about $300 to $600 or more per session,¹¹ and Spravato is billed to insurance for those who qualify and are approved, or paid out of pocket otherwise. Whichever path fits, treatment starts with the same online clinical evaluation.